Provided by Tiger Fintech (Singapore) Pte. Ltd.

RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD

5.26
+0.09001.74%
Post-market: 5.260.00000.00%18:15 EDT
Volume:16.24K
Turnover:84.78K
Market Cap:41.47M
PE:-1.45
High:5.31
Open:5.30
Low:4.98
Close:5.17
52wk High:50.82
52wk Low:3.50
Shares:7.88M
Float Shares:5.32M
Volume Ratio:0.32
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6237
EPS(LYR):-3.6237
ROE:-109.20%
ROA:-27.70%
PB:1.41
PE(LYR):-1.45

Loading ...

Company Profile

Company Name:
RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
14
Office Location:
62 Lygon Street,Level 3,Carlton,Victoria,Australia
Zip Code:
3053
Fax:
61 3 9822 7735
Introduction:
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.

Directors

Name
Position
Paul Hopper
Executive Chairman
Hester Larkin
Non-Executive Director
Ian Turner
Non-Executive Director
Leila Alland
Non-Executive Director
Noel Donnelly
Non-Executive Director
Phillip Hains
Executive Director, Chief Financial Officer and Company Secretary

Shareholders

Name
Position
Riccardo Canevari
Chief Executive Officer and Managing Director
Phillip Hains
Executive Director, Chief Financial Officer and Company Secretary
Dimitris Voliotis
Chief Medical Officer
Nathan Jong
Secretary
Paul Hopper
Executive Chairman